CELZ vs. GAIN

Last updated Apr 1, 2026

Compare and contrast key facts about Creative Medical Technology Holdings Inc (CELZ) and Gladstone Investment Corporation (GAIN).

Performance

CELZ vs. GAIN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Creative Medical Technology Holdings Inc (CELZ) and Gladstone Investment Corporation (GAIN). The values are adjusted to include any dividend payments, if applicable.

CELZ vs. GAIN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CELZ Creative Medical Technology Holdings Inc	5.10%	-15.15%	-49.89%	20.97%	-82.76%	-84.10%	-38.22%	-96.96%	-26.81%	-97.35%
GAIN Gladstone Investment Corporation	3.42%	17.11%	5.33%	31.01%	-17.55%	82.14%	-16.56%	53.31%	-9.67%	44.63%

Fundamentals

Market Cap CELZ : $4.91M GAIN : $563.43M
EPS CELZ : -$2.38 GAIN : $1.68
PS Ratio CELZ : 863.35 GAIN : 4.93
PB Ratio CELZ : 0.65 GAIN : 0.95
Total Revenue (TTM) CELZ : $6.00K GAIN : $110.43M
Gross Profit (TTM) CELZ : $3.81K GAIN : $60.00M
EBITDA (TTM) CELZ : -$6.02M GAIN : $64.46M

Returns By Period

In the year-to-date period, CELZ achieves a 5.10% return, which is significantly higher than GAIN's 3.42% return. Over the past 10 years, CELZ has underperformed GAIN with an annualized return of -56.37%, while GAIN has yielded a comparatively higher 18.49% annualized return.

CELZ

• 1D: 6.19%
• 1M: 13.81%
• YTD: 5.10%
• 6M: -38.14%
• 1Y: -5.07%
• 3Y*: -25.59%
• 5Y*: -58.69%
• 10Y*: -56.37%

GAIN

• 1D: 0.35%
• 1M: 4.32%
• YTD: 3.42%
• 6M: 6.37%
• 1Y: 18.02%
• 3Y*: 16.28%
• 5Y*: 14.72%
• 10Y*: 18.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CELZ vs. GAIN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CELZ

CELZ Risk / Return Rank: 41
CELZ Sharpe Ratio Rank: 37
CELZ Sortino Ratio Rank: 46
CELZ Omega Ratio Rank: 47
CELZ Calmar Ratio Rank: 36
CELZ Martin Ratio Rank: 37

GAIN

GAIN Risk / Return Rank: 70
GAIN Sharpe Ratio Rank: 72
GAIN Sortino Ratio Rank: 68
GAIN Omega Ratio Rank: 67
GAIN Calmar Ratio Rank: 68
GAIN Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CELZ vs. GAIN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Creative Medical Technology Holdings Inc (CELZ) and Gladstone Investment Corporation (GAIN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CELZ	GAIN	Difference
Sharpe ratio Return per unit of total volatility	-0.05	0.84	-0.89
Sortino ratio Return per unit of downside risk	0.67	1.44	-0.76
Omega ratio Gain probability vs. loss probability	1.10	1.19	-0.09
Calmar ratio Return relative to maximum drawdown	-0.14	1.23	-1.36
Martin ratio Return relative to average drawdown	-0.22	5.23	-5.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CELZ vs. GAIN - Sharpe Ratio Comparison

The current CELZ Sharpe Ratio is -0.05, which is lower than the GAIN Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of CELZ and GAIN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CELZ	GAIN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.05	0.84	-0.89
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.44	0.68	-1.11
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.04	0.73	-0.77
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	0.24	-0.27

Correlation

The correlation between CELZ and GAIN is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CELZ vs. GAIN - Dividend Comparison

CELZ has not paid dividends to shareholders, while GAIN's dividend yield for the trailing twelve months is around 10.56%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CELZ Creative Medical Technology Holdings Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
GAIN Gladstone Investment Corporation	10.56%	10.74%	12.53%	17.24%	9.88%	6.06%	9.22%	7.06%	9.24%	7.94%	8.87%	9.68%

Drawdowns

CELZ vs. GAIN - Drawdown Comparison

The maximum CELZ drawdown since its inception was -100.00%, which is greater than GAIN's maximum drawdown of -80.87%. Use the drawdown chart below to compare losses from any high point for CELZ and GAIN.

Drawdown Indicators

	CELZ	GAIN	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-80.87%	-19.13%
Max Drawdown (1Y) Largest decline over 1 year	-68.16%	-13.01%	-55.15%
Max Drawdown (5Y) Largest decline over 5 years	-99.34%	-26.26%	-73.08%
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	-56.28%	-43.72%
Current Drawdown Current decline from peak	-100.00%	-1.24%	-98.76%
Average Drawdown Average peak-to-trough decline	-85.43%	-16.03%	-69.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	41.22%	3.05%	+38.17%

Volatility

CELZ vs. GAIN - Volatility Comparison

Creative Medical Technology Holdings Inc (CELZ) has a higher volatility of 11.68% compared to Gladstone Investment Corporation (GAIN) at 7.41%. This indicates that CELZ's price experiences larger fluctuations and is considered to be riskier than GAIN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CELZ	GAIN	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.68%	7.41%	+4.27%
Volatility (6M) Calculated over the trailing 6-month period	69.13%	12.15%	+56.98%
Volatility (1Y) Calculated over the trailing 1-year period	100.88%	21.66%	+79.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	134.02%	21.94%	+112.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	1,441.83%	25.41%	+1,416.42%

Financials